These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 9711896)

  • 21. Neoadjuvant chemotherapy using low-dose consecutive intraarterial infusions of cisplatin combined with 5-fluorouracil for locally advanced cervical adenocarcinoma.
    Aoki Y; Sato T; Watanabe M; Sasaki M; Tsuneki I; Tanaka K
    Gynecol Oncol; 2001 Jun; 81(3):496-9. PubMed ID: 11371145
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Value of serial carcinoembryonic antigen levels in evaluating the response to chemotherapy in patients with advanced digestive cancers.
    Ychou M; Duffour J; Kramar A; Grenier J
    Oncol Rep; 1998; 5(5):1245-50. PubMed ID: 9683844
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A case of metastatic colon carcinoma in which a continuous intrahepatic artery-infusion of 5-FU leucovorin and cisplatin, and systemic chemotherapy with CPT-11 was very effective].
    Ishikawa T; Nakamura M; Ohkuma K; Hisano C; Nakano S; Maruyama T; Kaji Y; Niho Y; Masumoto N
    Gan To Kagaku Ryoho; 2000 Aug; 27(9):1443-7. PubMed ID: 10969604
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Continuous infusion of 5-fluorouracil and low dose cisplatin infusion for the treatment of advanced and recurrent gastric adenocarcinoma.
    Chung YS; Yamashita Y; Inoue T; Matsuoka T; Nakata B; Onoda N; Maeda K; Sawada T; Kato Y; Shirasaka T; Sowa M
    Cancer; 1997 Jul; 80(1):1-7. PubMed ID: 9210702
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Randomized trial of 5-fluorouracil, leucovorin and cisplatin in advanced pancreatic cancer.
    Huguier M; Barrier A; Valinas R; Flahault A; Adloff M; Pezet D; Jaeck D; Millat B;
    Hepatogastroenterology; 2001; 48(39):875-8. PubMed ID: 11462946
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pilot study of celecoxib and infusional 5-fluorouracil as second-line treatment for advanced pancreatic carcinoma.
    Milella M; Gelibter A; Di Cosimo S; Bria E; Ruggeri EM; Carlini P; Malaguti P; Pellicciotta M; Terzoli E; Cognetti F
    Cancer; 2004 Jul; 101(1):133-8. PubMed ID: 15221998
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Locally advanced unresectable gastric cancer successfully resected after neoadjuvant chemotherapy with FADE regimen.
    Chung HC; Roh JK; Park YJ; Lee SI; Min JS; Lee JT; Lee KB; Kim BS
    Yonsei Med J; 1990 Mar; 31(1):74-9. PubMed ID: 2346043
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A case of far-advanced gastric cancer treated with continuous 5-fluorouracil injection and intrahepatic arterial infusion of low-dose cisplatin].
    Ueno T; Oka M
    Gan To Kagaku Ryoho; 1997 Sep; 24(12):1855-7. PubMed ID: 9382550
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combination chemotherapy of continuous 5-FU infusion and low-dose cisplatin infusion for the treatment of advanced and recurrent gastric and colorectal adenocarcinomas.
    Tsuji A; Morita S; Horimi T; Takasaki M; Takahashi I; Shirasaka T
    Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():528-34. PubMed ID: 10895205
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Resection of pancreatic cancer and simultaneous lung metastasis--a case report of successful in tumor dormancy mainly by postoperative 5-fluorouracil-based chemotherapy].
    Baba H; Goseki N; Takamatsu S; Nosaka T; Teramoto K; Arii S; Kumagai J
    Gan To Kagaku Ryoho; 2002 Nov; 29(12):2382-5. PubMed ID: 12484080
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemoradiotherapy in the treatment of regional pancreatic carcinoma: a phase II study.
    Al-Sukhun S; Zalupski MM; Ben-Josef E; Vaitkevicius VK; Philip PA; Soulen R; Weaver D; Adsay V; Heilbrun LK; Levin K; Forman JD; Shields AF
    Am J Clin Oncol; 2003 Dec; 26(6):543-9. PubMed ID: 14663369
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A case of advanced gastric cancer responding to combination chemotherapy with low-dose 5-FU plus CDDP].
    Ishio T; Kohnoe S; Endo K; Yamamoto M; Ikeda Y; Toh Y; Baba H; Okamura T; Kawamoto K
    Gan To Kagaku Ryoho; 2002 Sep; 29(9):1627-30. PubMed ID: 12355950
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Investigation into the usefulness and adverse events of CDDP, 5-fU and dl-leucovorin (PFL-therapy) for advanced colorectal cancer.
    Okabe S; Ishikawa T; Tanami H; Kuwabara H; Fukahara T; Udagawa M; Ootsukasa S; Arai T; Maruyama S; Murase N; Yamashita H; Iwai T
    J Med Dent Sci; 2002 Jun; 49(2):77-84. PubMed ID: 12627817
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neoadjuvant therapy of high-risk gastric cancer: a phase II trial of preoperative FAMTX and postoperative intraperitoneal fluorouracil-cisplatin plus intravenous fluorouracil.
    Kelsen D; Karpeh M; Schwartz G; Gerdes H; Lightdale C; Botet J; Lauers G; Klimstra D; Huang Y; Saltz L; Quan V; Brennan M
    J Clin Oncol; 1996 Jun; 14(6):1818-28. PubMed ID: 8656250
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combined-modality therapy for esophageal cancer: phase I trial of escalating doses of paclitaxel in combination with cisplatin, 5-fluorouracil, and high-dose radiation before esophagectomy.
    Weiner LM; Colarusso P; Goldberg M; Dresler C; Coia LR
    Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-93-S19-95. PubMed ID: 9427276
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical benefit with cisplatin, hydroxyurea and 5-fluorouracil/leucovorin in advanced pancreatic adenocarcinoma.
    Raymond E; de Gramont A; Louvet C; Tournigand C; Demuynck B; Beerblock K; Carola E; Krulik M
    Eur J Cancer; 1997 Apr; 33(4):696-7. PubMed ID: 9274458
    [No Abstract]   [Full Text] [Related]  

  • 37. [Trial of outpatient anti-cancer chemotherapy with infusion of 5-FU and cisplatin for advanced gastric and colorectal cancers].
    Suzuki H; Kanou Y; Ooshima H; Kawase J; Kudou J; Mizuno Y; Matsumoto S
    Gan To Kagaku Ryoho; 2005 Feb; 32(2):189-93. PubMed ID: 15751631
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phase III trial of postoperative cisplatin, interferon alpha-2b, and 5-FU combined with external radiation treatment versus 5-FU alone for patients with resected pancreatic adenocarcinoma -- CapRI: study protocol [ISRCTN62866759].
    Knaebel HP; Märten A; Schmidt J; Hoffmann K; Seiler C; Lindel K; Schmitz-Winnenthal H; Fritz S; Herrmann T; Goldschmidt H; Krempien R; Mansmann U; Debus J; Diehl V; Büchler MW
    BMC Cancer; 2005 Apr; 5():37. PubMed ID: 15826316
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Docetaxel and continuous-infusion fluorouracil versus epirubicin, cisplatin, and fluorouracil for advanced gastric adenocarcinoma: a randomized phase II study.
    Thuss-Patience PC; Kretzschmar A; Repp M; Kingreen D; Hennesser D; Micheel S; Pink D; Scholz C; Dörken B; Reichardt P
    J Clin Oncol; 2005 Jan; 23(3):494-501. PubMed ID: 15659494
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A case of unresectable pancreatic cancer responding to MTX/5-FU sequential therapy].
    Takahashi N; Masamune R; Kunii Y
    Gan To Kagaku Ryoho; 1999 Jan; 26(1):153-5. PubMed ID: 9987514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.